Publications by authors named "Ramkumar Subramanian"

Claim this Profile
B
Biomarkers.
Vijay Benade, Anil Shinde, Rajesh Kumar Badange, Mohammed Abdul Rasheed, Ramkumar Subramanian

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Development.
Ramakrishna Nirogi, Renny Abraham, Jyothsna Ravulu, Satish Jetta, Vijay Benade, Ramkumar Subramanian

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany.
Nicholas Durno, Pablo Arija, Krystallia Pantiri, Marieke Heisen, Marco Boeri, Ramkumar Subramanian

J Dermatolog Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
Ramakrishna Nirogi, Anil Shinde, Vinod Kumar Goyal, Jyothsna Ravula, Vijay Benade, Ramkumar Subramanian

Sleep Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usmarapride (SUVN-D4010), a 5-HT receptor partial agonist for the potential treatment of Alzheimer's disease: Behavioural, neurochemical and pharmacological profiling.
Ramakrishna Nirogi, Venkata Ramalingayya Grandhi, Rajeshbabu Medapati, Narender Ganuga, Renny Abraham, Ramkumar Subramanian

Eur J Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study.
Ramakrishna Nirogi, Vinod Kumar Goyal, Vijay Benade, Ramkumar Subramanian, Jyothsna Ravula

Neurol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses.
Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, Anil Shinde, Vinod Kumar Goyal, Ramkumar Subramanian

Int J Geriatr Psychiatry· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization.
Ramakrishna Nirogi, Renny Abraham, Pradeep Jayarajan, Venkatesh Goura, Rajesh Kallepalli, Ramkumar Subramanian

Psychopharmacology (Berl)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal NASH prognosis using 3D imaging flow cytometry and artificial intelligence to characterize liver cells.
Ramkumar Subramanian, Rui Tang, Zunming Zhang, Vaidehi Joshi, Jeffrey N Miner

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H Receptor Inverse Agonist with Efficacy in Animal Models of Cognition.
Anil Karbhari Shinde, Rajesh Kumar Badange, Veena Reballi, Pramod Kumar Achanta, Kumar Bojja, Ramkumar Subramanian

ChemMedChem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer's Disease.
Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Karbhari Shinde, Shankar Reddy Gagginapally, Durga Malleshwari Kancharla, Ramkumar Subramanian

J Med Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders.
Ramakrishna Nirogi, Venkata R Grandhi, Rajesh B Medapati, Narender Ganuga, Vijay Benade, Ramkumar Subramanian

J Psychopharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation.
Ramakrishna Nirogi, Vijay Benade, Saivishal Daripelli, Ramkumar Subramanian, Venkatesh Kamuju

Psychopharmacology (Berl)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (HR) inverse agonist in clinical development for the treatment of narcolepsy.
Ramakrishna Nirogi, Gopinadh Bhyrapuneni, Nageswara Rao Muddana, Arunkumar Manoharan, Anil K Shinde, Ramkumar Subramanian

Eur J Pharm Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression.
Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil K Shinde, Srinivasa Rao Ravella, Narsimha Bogaraju, Ramkumar Subramanian

J Med Chem· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization.
Ramakrishna Nirogi, Renny Abraham, Vijay Benade, Rajesh B Medapati, Pradeep Jayarajan, Ramkumar Subramanian

Behav Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H Receptor Inverse Agonist with Robust Wake-Promoting Activity.
Ramakrishna Nirogi, Anil Shinde, Abdul Rasheed Mohammed, Rajesh Kumar Badange, Veena Reballi, Ramkumar Subramanian

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT Receptor Partial Agonists.
Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil K Shinde, Shankar Reddy Gagginapally, Durga Malleshwari Kancharla, Ramkumar Subramanian

J Med Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT) Receptor Antagonist for Potential Treatment of Alzheimer's Disease.
Ramakrishna Nirogi, Anil Shinde, Rama Sastry Kambhampati, Abdul Rasheed Mohammed, Sangram Keshari Saraf, Ramkumar Subramanian

J Med Chem· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient Induced Molecular Electronic Spectroscopy (TIMES) for study of protein-ligand interactions.
Tiantian Zhang, Ti-Hsuan Ku, Yuanyuan Han, Ramkumar Subramanian, Iftikhar Ahmad Niaz

Sci Rep· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists.
Ramakrishna Nirogi, Anil Shinde, Vinaykumar Tiriveedhi, Laxman Kota, Sangram Keshari Saraf, Ramkumar Subramanian

Eur J Med Chem· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.
Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil K Shinde, Narsimha Bogaraju, Shankar Reddy Gagginapalli, Ramkumar Subramanian

Eur J Med Chem· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Energy-filtered cold electron transport at room temperature.
Pradeep Bhadrachalam, Ramkumar Subramanian, Vishva Ray, Liang-Chieh Ma, Weichao Wang

Nat Commun· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT₆ receptor antagonists.
Ramakrishna Nirogi, Anil Shinde, Anand Daulatabad, Ramasastri Kambhampati, Parandhama Gudla, Ramkumar Subramanian

J Med Chem· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMOS-compatible fabrication of room-temperature single-electron devices.
Vishva Ray, Ramkumar Subramanian, Pradeep Bhadrachalam, Liang-Chieh Ma, Choong-Un Kim

Nat Nanotechnol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis